Britsch S (2007). "Introduction: Molecular Control of Development". The Neuregulin-I/ErbB Signaling System in Development and Disease. Advances in Anatomy Embryology and Cell Biology. Vol. 190. pp. 1–65. doi:10.1007/978-3-540-37107-6_1. ISBN978-3-540-37105-2. PMID17432114.
Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM (December 2006). "A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms". Nat. Neurosci. 9 (12): 1477–8. doi:10.1038/nn1795. PMID17072305. S2CID10338687.
Deng C, Pan B, Engel M, Huang XF (February 2013). "Neuregulin-1 signalling and antipsychotic treatment: Potential therapeutic targets in a schizophrenia candidate signalling pathway". Psychopharmacology. 226 (2): 201–15. doi:10.1007/s00213-013-3003-2. PMID23389757. S2CID164430.
Xu Y, Li X, Liu X, Zhou M (2010). "Neuregulin-1/ErbB Signaling and Chronic Heart Failure". Cardiovascular Pharmacology - Heart and Circulation. Advances in Pharmacology. Vol. 59. pp. 31–51. doi:10.1016/S1054-3589(10)59002-1. ISBN9780123849038. PMID20933198.
Boateng SY, Lateef SS, Mosley W, Hartman TJ, Hanley L, Russell B (January 2005). "RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes". Am. J. Physiol., Cell Physiol. 288 (1): C30–8. doi:10.1152/ajpcell.00199.2004. PMID15371257.
Bassani JW, Yuan W, Bers DM (May 1995). "Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes". Am. J. Physiol. 268 (5 Pt 1): C1313–9. doi:10.1152/ajpcell.1995.268.5.C1313. PMID7762626.
Britsch S (2007). "Introduction: Molecular Control of Development". The Neuregulin-I/ErbB Signaling System in Development and Disease. Advances in Anatomy Embryology and Cell Biology. Vol. 190. pp. 1–65. doi:10.1007/978-3-540-37107-6_1. ISBN978-3-540-37105-2. PMID17432114.
Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM (December 2006). "A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms". Nat. Neurosci. 9 (12): 1477–8. doi:10.1038/nn1795. PMID17072305. S2CID10338687.
Deng C, Pan B, Engel M, Huang XF (February 2013). "Neuregulin-1 signalling and antipsychotic treatment: Potential therapeutic targets in a schizophrenia candidate signalling pathway". Psychopharmacology. 226 (2): 201–15. doi:10.1007/s00213-013-3003-2. PMID23389757. S2CID164430.
Xu Y, Li X, Liu X, Zhou M (2010). "Neuregulin-1/ErbB Signaling and Chronic Heart Failure". Cardiovascular Pharmacology - Heart and Circulation. Advances in Pharmacology. Vol. 59. pp. 31–51. doi:10.1016/S1054-3589(10)59002-1. ISBN9780123849038. PMID20933198.
Boateng SY, Lateef SS, Mosley W, Hartman TJ, Hanley L, Russell B (January 2005). "RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes". Am. J. Physiol., Cell Physiol. 288 (1): C30–8. doi:10.1152/ajpcell.00199.2004. PMID15371257.
Bassani JW, Yuan W, Bers DM (May 1995). "Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes". Am. J. Physiol. 268 (5 Pt 1): C1313–9. doi:10.1152/ajpcell.1995.268.5.C1313. PMID7762626.
Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM (December 2006). "A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms". Nat. Neurosci. 9 (12): 1477–8. doi:10.1038/nn1795. PMID17072305. S2CID10338687.
Deng C, Pan B, Engel M, Huang XF (February 2013). "Neuregulin-1 signalling and antipsychotic treatment: Potential therapeutic targets in a schizophrenia candidate signalling pathway". Psychopharmacology. 226 (2): 201–15. doi:10.1007/s00213-013-3003-2. PMID23389757. S2CID164430.
Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL, Einheber S, Salzer JL (2008). "Type III neuregulin-1 promotes oligodendrocyte myelination". Glia. 56 (3): 284–93. doi:10.1002/glia.20612. PMID18080294. S2CID26539423.